BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 12, 2025
See today's BioWorld
Home
» A sign of the times in Japan: Astellas shutters two units, hands another to Eurofins
To read the full story,
subscribe
or
sign in
.
A sign of the times in Japan: Astellas shutters two units, hands another to Eurofins
July 5, 2018
By
Catherine Makino
TOKYO – Japanese pharmaceutical companies are downsizing, bucking a longstanding practice in the country of providing lifetime employment, even as they try to prepare for the possibility of a shrinking industry.
BioWorld